COVID-19: Vaccinations paused in Mangaung due to protests
Service delivery protests in Mangaung in the Free State have disrupted the vaccine rollout in the metro. Vaccinations are on hold for now, reports Refilwe Mochoari.
Analysis: We need to do for TB vaccines what we’ve done for COVID-19
It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. It’s called VJS or vaccine jealousy syndrome, writes Chris Bateman.
COVID-19: What provinces have planned for older persons
Phase II of South Africa’s vaccination rollout has started. Elri Voigt unpacks how provinces will go about vaccinating those aged 60 and older.
Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured
When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.
How to vaccinate millions as quickly as possible
Starting now, hundreds of thousands of COVID-19 vaccines will be arriving in South Africa weekly. Rather than spending energy and resources policing who gets them, we should be focusing on getting the vaccines as fast as possible into willing arms. Don’t try to micro-manage the rollout, writes Nathan Geffen and Marcus Low.
UPDATE: How provinces are gearing up for the launch of mass vaccination
With phase two of the country’s vaccination rollout set to start on Monday, 17 May, provinces are gearing up for the largest adult vaccination push the country has ever seen. Elri Voigt provides an update on preparations for the next phase in the nine provinces and progress made in vaccinating healthcare workers through the Sisonke implementation study.
New HIV/TB plan delayed by a year because of COVID-19
South Africa will delay introducing a new HIV and TB plan until 2024, Deputy President David Mabuza revealed on Wednesday. The plan is delayed to allow the country’s HIV and TB responses to recover from COVID-19-related disruptions. Laura Lopez Gonzalez reports for Spotlight.
COVID-19: Do I still need to wear a mask when vaccinated, and other questions
With the COVID-19 mass vaccination rollout set to start on 17 May, many more people, for now, those older than 60 years, will receive their jabs. Elri Voigt looked into what, if anything, will change for those who have been vaccinated, and what other countries have done in this regard.
COVID-19: Is the Free State ready for a third wave?
COVID-19 numbers have in recent weeks been rising in the Free State, leading some to fear that the province might be at the beginning of a third wave of infections. Refilwe Mochoari asked the Department of Health, unions, and opposition political parties whether the province is ready for a third wave.
Ubuntu: COVID-19 and human rights sacrifice in SA
Public health emergencies place immense power in the hands of executive leadership. This can pose a risk of creeping authoritarianism. Professor Narnia Bohler-Muller and Dr Benjamin Roberts explore the lessons that can be drawn from the findings of the University of Johannesburg and the Human Sciences Research Council’s online survey on the public’s views on lockdown regulations.
Editorial: Once mass vaccinations start, we need to administer at least 250 000 doses per day
On 17 May South Africa’s mass COVID-19 vaccination programme is expected to finally kick off. This will start a long race against the clock in which every day and every vaccination matters. We should aim to administer at least 250 000 vaccine doses a day, writes Spotlight editor Marcus Low.
XACT III: A trial asking how to take TB tests to the people
Roughly two in five people newly ill with TB worldwide are never diagnosed. In South Africa, this amounts to about 120 000 to 160 000 people per year. A large new study called XACT III is testing ways in which more people can be diagnosed and started on TB treatment more quickly. Tiyese Jeranji reports.
